Coronary Artery Stents in Heart Failure With Preserved Ejection Fraction

Abroad (travel likely)RecruitingPHASE2

Conditions

Heart Failure With Preserved Ejection Fraction (HFPEF) · Coronary Artery Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom
Contact: Study coordinator (Matthew Ryan) · matthew.ryan@kcl.ac.uk · +442071881041

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study to Evaluate Safety, Tolerability and Drug Levels of BMS-986435/MYK-224 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)

Heart Failure

IsraelRecruitingPHASE2

Birmingham, United States · Lakewood, United States

A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)

Heart · Heart Failure With Preserved Ejection Fraction (HFPEF)

Abroad (travel likely)RecruitingPHASE1

Little Rock, United States · Huntington Beach, United States

SGLT2i and KNO3 in HFpEF - The SAK HFpEF Trial

Heart Failure With Preserved Ejection Fraction

Abroad (travel likely)RecruitingPHASE2

Philadelphia, United States

ELEVATE-HFpEF Clinical Study

Heart Failure With Preserved Ejection Fraction (HFpEF)

Abroad (travel likely)Recruiting

Phoenix, United States · San Francisco, United States